Haleos Labs closes trading window from July 1 until Q1FY27 results
Haleos Labs Limited has shut its trading window for designated persons starting July 1, 2026, complying with SEBI regulations. The window will reopen 48 hours after the Q1FY27 results are announced. The Board meeting date for the quarter ended June 30, 2026, is pending a separate announcement.

*this image is generated using AI for illustrative purposes only.
Haleos Labs Limited has closed its trading window for designated persons and connected persons effective July 1, 2026, to prevent insider trading ahead of its financial results. The restriction will remain in force until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This measure is in accordance with the company's Code of Conduct for Prevention of Insider Trading and Clause 4 of Schedule B of the SEBI (Prohibition of Insider Trading) Regulations 2015.
The closure applies to designated persons, specified connected persons, and their immediate relatives within the company and its subsidiaries. The specific date for the Board meeting to consider the unaudited financial results for the quarter ended June 30, 2026, will be communicated separately in due course.
| Event | Date / Time |
|---|---|
| Trading Window Closure | July 1, 2026 |
| Trading Window Reopens | 48 hours after Q1FY27 results declaration |
| Quarter End | June 30, 2026 |
| Board Meeting Date | To be informed separately |
Historical Stock Returns for Haleos
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.96% | +3.43% | -7.43% | +11.66% | +26.08% | +131.46% |
What market expectations are currently priced into Haleos Labs' stock ahead of the Q1FY27 results?
How might the extended trading restriction impact liquidity and trading volume for Haleos Labs shares?
Could the timing of the Board meeting suggest a deviation from the company's historical earnings release schedule?


































